OTC · Biotechnology

Satellos Bioscience Inc. (MSCLF) Stock

$6.25 +11.81% OTC: MSCLF Healthcare

Satellos Bioscience Inc., a company dedicated to regenerative medicine, focuses on pioneering treatments for various degenerative muscle conditions. A cornerstone of their research is a leading program aimed at developing an orally administered drug.

Valuation

MetricValue
Price$6.25
Market Cap$96.62M
P/E Ratio-1.75
P/B Ratio0.49
P/S Ratio0.00
EPS (TTM)$-20.40
52-Week High$12.50
52-Week Low$0.88
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-51.42%
ROA-25.56%
ROCE-20.67%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio11.13

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-7.0M$-8.0M$0$0$-26.0M
Net Profit$-16.0M$-11.0M$0$0$-25.0M
EPS$-7.68$-3.80$0.00$0.00$-20.40
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$13.0M$6.0M$44.0M$73.0M$32.0M
Total Liabilities$2.0M$3.0M$4.0M$5.0M$4.0M
Cash$5.0M$2.0M$22.0M$58.0M$10.0M
Borrowings$0$0$0$0$0

Latest News

Eaton Vance Worldwide Health Sciences Fund's Biggest Q2 2026 Move: Zoetis Inc Slashed 45. ... GuruFocus.com · Jul 27, 2026 In HelloNation, Financial Planning Expert Greg Harrison Explains How to Calculate a Financial Independence Number PR Newswire · Jul 27, 2026 Contracting Expert Brice Bishop Explains Why Roof Ventilation Matters in HelloNation PR Newswire · Jul 27, 2026 First Time Home Buying Made Clear by Real Estate Expert Wade Budinetz of Bethlehem, Pennsylvania for HelloNation PR Newswire · Jul 27, 2026 Strategic Value Partners Fund to Acquire Minority Stake in South Field Energy PR Newswire · Jul 27, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-5.0M$-6.0M$-15.0M$-25.0M$-24.0M
Investing Cash Flow$2.0M$0$-18.0M$6.0M$-9.0M
Financing Cash Flow$0$0$0$11.0M$0
Net Cash Flow$4.0M$-3.0M$20.0M$36.0M$-30.0M
Free Cash Flow$-5.0M$-6.0M$-15.0M$-25.0M$-24.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-5.09
FCF Yield-22.99%
Quick Ratio11.13
Interest Coverage0.00
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BSEMBioStem Technologies, Inc. $4.01 +4.59% -3.40 $68.11M 0.00%
HSCHFH-Source Holdings Ltd. $0.00 — 0.00 $1176 0.00%
IUGNFImugene Limited $0.10 +0.00% -0.40 $41.60M 0.00%
KNTPFKintor Pharmaceutical Limited $0.23 -0.20% -3.33 $107.85M 0.00%
PBIGFParadigm Biopharmaceuticals Limited $0.12 -5.44% -1.91 $52.01M 0.00%

About Satellos Bioscience Inc.

Satellos Bioscience Inc., a company dedicated to regenerative medicine, focuses on pioneering treatments for various degenerative muscle conditions. A cornerstone of their research is a leading program aimed at developing an orally administered drug. This therapeutic seeks to rectify muscle stem cell polarity, which in turn is intended to restore the body's natural processes for muscle repair and regeneration. The enterprise was founded in 2012 and operates from its primary offices located in Toronto, Canada.

Satellos Bioscience Inc. is headquartered in CA.

Satellos Bioscience Inc. (MSCLF) stock trades at $6.25 with a market capitalization of $96.62M. The stock is valued at a price-to-earnings (P/E) ratio of -1.75, price-to-book of 0.49, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.88 and $12.50, and currently trades 50.0% below its 52-week high.

On profitability, Satellos Bioscience Inc. generates a return on equity (ROE) of -51.42%, return on capital employed of -20.67%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: satellos.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides